Approval · Notice of Compliance 20858 · 2018
PLAN B: Notice of Compliance 20858
Issued May 9, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20858
- Date
- May 9, 2018
- Company
- Foundation Consumer Healthcare, LlcPittsburgh, Pennsylvania, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB
- LEVONORGESTREL 1.5 MG per TAB